Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

forxiga

AstraZeneca scores positive real-world Forxiga data

September 16, 2015 Research and Development AstraZeneca, EASD, European Association for the Study of Diabetes, Forxiga, dapagliflozin, exenatide, real world data, real world evidence

The real-world study of AstraZeneca’s diabetes drug Forxiga has found its use in UK patients primary care patients supports the …
News
mike_maclean

PureTech appoints Michael MacLean as chief financial officer

September 14, 2015 Medical Communications, Research and Development, Sales and Marketing Michael MacLean, PureTech Health

PureTech Health has appointed Michael MacLean to the management team, as chief financial officer and executive vice president. Michael MacLean …
Appointment

Counting the true cost of the Cancer Drugs Fund cuts

September 14, 2015 Research and Development Cancer, Cancer Drugs Fund, NHS, clinical trials, cuts, oncology

Leading figures from the pharma industry and cancer charities reacted with dismay to the recent cuts to the Cancer Drugs …
Feature
lab sign

Medimmune and Cancer Research UK launch new drug discovery lab

September 11, 2015 Research and Development AstraZeneca, Cambridge, Cancer, Cancer Research UK, MedImmune, R&D, george freeman

MedImmune and the UK’s biggest cancer charity have opened a new laboratory for joint cancer research.Research at the laboratory, which …
News
body scan

Pfizer in metabolic disease push

September 11, 2015 Medical Communications, Research and Development AMRA, Pfizer, UK Biobank, med tech, metabolic disease, obesity

Pfizer has signed a research collaboration with a global medical health technology company, to investigate risk factors for metabolic conditions.  …
News
zs-pharma-logo_cmyk

Actelion confirms takeover talks with ZS Pharma

September 11, 2015 Research and Development, Sales and Marketing Actelion, Shire, ZS Pharma, mergers and acquisitions

Swiss drugmaker Actelion has entered discussions with US biotech company ZS Pharma, over a takeover thought to be worth $2.5 …
News
john_jeans

EM Imaging appoints new chairman

September 10, 2015 Manufacturing and Production, Research and Development EM Imaging, Optometry, ophthalmology

The board of Edinburgh Molecular Imaging Ltd (EM Imaging) is pleased to announce the appointment of John Jeans as non-executive …
Appointment
Truvada pill

Gilead’s Truvada prevents HIV infections in high-risk men

September 10, 2015 Research and Development Gilead, HIV, PrEP, Truvada, pre-exposure prophylaxis treatment, sexually transmitted infections

UK researchers say Truvada, Gilead’s HIV prevention treatment, should be added to the country’s ‘HIV prevention toolkit’, after a study …
News
Westminster

Pharma leaders urge UK Government not to cut spending

September 9, 2015 Research and Development Autumn spending review, George Osborne, R&D, government, research, research and development, research funding

Representatives of more than 200 life sciences organisations have urged the UK government to protect the sector from spending cuts. …
News
Alzheimer's research

Neurimmune kicks off late-stage Alzheimer’s study

September 9, 2015 Research and Development Alzheimer's disease, Biogen, Neurimmune, aducanumab, neurology

Neurimmune and its development partner Biogen are beginning a Phase III study of the companies’ potential Alzheimer’s treatment aducanumab.  The …
News
asthma inhalers

GSK suffers Breo late-stage trial blow

September 9, 2015 Research and Development COPD, GSK, Revlar, asthma, breo, clinical trial, phase III

GSK has hit a setback in its plans to expand sales of its blockbuster asthma treatment Breo, after a major …
News
michael_koslowski_picture

Mission Therapeutics appoints new chief medical officer

September 9, 2015 Medical Communications, Research and Development Dr Michael Koslowski, Mission Therapeutics

Mission Therapeutics has announced the appointment of Dr Michael Koslowski as chief medical officer. Dr Koslowski brings over 15 years’ …
Appointment
unisa_research_building

Yabao Pharmaceutical and UniSA embark on joint venture

September 9, 2015 Research and Development Cancer, Yabao Pharmaceutical

Yabao Pharmaceutical and the University of South Australia (UniSA) have joined together in a collaboration to develop new treatments for …
News
avastin

New treatment option for ovarian cancer patients in Scotland

September 8, 2015 Medical Communications, Research and Development, Sales and Marketing Roche, Scotland, avastin, ovarian cancer

The Scottish Medicines Consortium (SMC) has approved the use of Avastin in combination with paclitaxel chemotherapy as a treatment for women …
News
Europe flag

EMA launches project to boost early patient access to drugs

September 8, 2015 Research and Development EMA, European Medicines Agency, MAPPs, adaptive pathways, drug development, market access

The EMA is launching an adaptive pathway project to bring new medicinal products to market in Europe.  The ADAPT SMART …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026